{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.464.1003.196.12.1450",
  "meta" : {
    "versionId" : "2",
    "lastUpdated" : "2019-02-26T22:31:37.000-05:00",
    "profile" : ["http://hl7.org/fhir/StructureDefinition/shareablevalueset",
    "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
    "valueString" : "NCQA PHEMUR Author"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
    "valueDate" : "2022-12-15"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate" : "2019-02-26"
  }],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1450",
  "identifier" : [{
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.3.464.1003.196.12.1450"
  }],
  "version" : "20170504",
  "name" : "BrompheniramineCodeinePseudoephedrine",
  "title" : "Brompheniramine / Codeine / Pseudoephedrine",
  "status" : "active",
  "experimental" : false,
  "date" : "2017-05-04T01:00:13-04:00",
  "publisher" : "NCQA PHEMUR",
  "jurisdiction" : [{
    "extension" : [{
      "url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason",
      "valueString" : "UNKNOWN"
    }]
  }],
  "purpose" : "(Clinical Focus: This value set contains concepts that represent brompheniramine / codeine / pseudoephedrine combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; brompheniramine / codeine / pseudoephedrine (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; brompheniramine / codeine / pseudoephedrine in combination with other medications.)",
  "compose" : {
    "include" : [{
      "valueSet" : ["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1451"]
    }]
  },
  "expansion" : {
    "identifier" : "urn:uuid:9a9dd1a1-2de3-4aad-8ef3-676c046aaa31",
    "timestamp" : "2023-09-26T08:54:47-04:00",
    "total" : 2,
    "offset" : 0,
    "parameter" : [{
      "name" : "count",
      "valueInteger" : 1000
    },
    {
      "name" : "offset",
      "valueInteger" : 0
    }],
    "contains" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "994289",
      "display" : "brompheniramine maleate 0.27 MG/ML / codeine phosphate 1.27 MG/ML / pseudoephedrine hydrochloride 2 MG/ML Oral Solution"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "994402",
      "display" : "brompheniramine maleate 0.4 MG/ML / codeine phosphate 1.5 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Solution"
    }]
  }
}